Licostinel

This classification denotes a neuroprotective agent with the molecular formula C8H3Cl2N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z3037LJTC, chemically known as 6,7-dichloro-5-nitro-2,3-quinoxalinedione but generally known as licostinel, which bears US NIH Compound Identifier 5486198. European Medicines Agency schedules Licostinel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08503MIG. The term LICOSTINEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). LICOSTINEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule licostinel under HS 29339990 and SITC 51577. As of Q4 2014, LICOSTINEL remains the US FDA Preferred Term for this commodity. Licostinel bears US NLM identifiers UMLS ID C0294340 and NCI Concept Code C73248. SMILES: CLC1C([N](=O)O)C2[NH]C(=O)C(=O)[NH]C2CC1CL.